Trial Search

Current Search Criteria:

Intervention: Vemlidy® film-coated tablets
Found 7 matching trials

Bioequivalence Study of Two Products of Tenofovir Alafenamide 25 mg Film Tablet in Healthy, Adult, Human Subjects

PHASE1

To compare the bioavailability and characterize the pharmacokinetic profile...

Status

Completed

Location

Lambda Therapeutic Research Ltd.

Start Date

2024-07-06

Trial ID

NCT06592300

Treatments Being Tested

Tenofovir Alafenamide Film coated TabletVemlidy® film-coated tablets

Safety Of Nrtis for Alzheimer's Therapeutic Advancement in Singapore Study

PHASE1

Recent studies have identified an association between Alzheimer's Disease (...

Status

Active Not Recruiting

Location

National University Hospital

Start Date

2025-06-30

Trial ID

NCT07210528

Treatments Being Tested

Emtricitabine (FTC)Descovy® (TAF/FTC)Placebo to Match Emtricitabine 200mg/Tenofovir Alafenamide 25 mg.Placebo Capsules to Match Emtricitabine Capsules, 200mg.

Study to Evaluate the Safety and Efficacy of Selgantolimod (SLGN)-Containing Combination Therapies for the Treatment of Chronic Hepatitis B (CHB)

PHASE2

The primary objectives of this study are to evaluate the safety and tolerab...

Status

Completed

Location

Liverpool Hospital

Start Date

2021-08-14

Trial ID

NCT04891770

Treatments Being Tested

Tenofovir AlafenamideVIR-2218NivolumabSelgantolimod

RIFT: Effect of Rifampicin on Plasma PK of FTC, TAF and Intracellular TFV-DP & FTC-TP

PHASE1

The purpose of this study is to look at the levels of three HIV medications...

Status

Completed

Location

Chelsea and Westminster Hospital NHS Foundation Trust

Start Date

2017-06-01

Trial ID

NCT03186482

Treatments Being Tested

Descovy® (TAF/FTC)Viread® (TDF)Rifadin® (Rifampicin)

Development of a Urine-Based Point-of-Care Test for Adherence to Antiretroviral Drugs

EARLY_PHASE1

This is a single-center, open label study to identify adherence levels of c...

Status

Completed

Location

HIV/AIDS Clinical Research Unit / University of Pittsburgh

Start Date

2020-08-31

Trial ID

NCT04302896

Treatments Being Tested

dolutegravir oral tablet 50mgemtricitabine/tenofovir alafenamide oral tablet 200mg/25mgtenofovir disoproxil fumarate oral tablet 300mglamivudine oral tablet 300mg

A Study to Evaluate Efficacy and Safety of Cabotegravir (CAB) Long Acting (LA) Plus (+) Rilpivirine (RPV) LA Versus BIKTARVY® (BIK) in Participants With Human Immunodeficiency Virus (HIV)-1 Who Are Virologically Suppressed

PHASE3

This study is designed to assess the antiviral activity and safety of a two...

Status

Completed

Location

GSK Investigational Site

Start Date

2020-11-09

Trial ID

NCT04542070

Treatments Being Tested

Cabotegravir TabletsCabotegravir Injectable Suspension (CAB LA)Rilpivirine TabletsRilpivirine Injectable Suspension (RPV LA)BIKTARVY Tablets (BIK)

REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE

PHASE4

Managing HIV well requires taking antiretroviral therapy (ART) every day, b...

Status

Recruiting

Location

CAN Community Health

Start Date

2026-06-17

Trial ID

NCT07476339

Treatments Being Tested

Bictegravir, emtricitabine, and tenofovir alafenamide
PreviousNext